Sunhee Kwon Ro
Impact in
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hematology top 5%
- Multiple Myeloma Research and Treatments
Papers in
-
- Multiple Myeloma Research and Treatments 6
- Acute Myeloid Leukemia Research 2
- Genetics 6
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3
- Chronic Lymphocytic Leukemia Research 3
- Co-authors
- Heinz Ludwig (3 shared papers)Roman Hájek (3 shared papers)Kefei Zhou (1 shared paper)Ola Landgren (1 shared paper)Bruno Paiva (1 shared paper)Hui Yang (1 shared paper)María‐Victoria Mateos (1 shared paper)Hervé Avet‐Loiseau (1 shared paper)
- Journals
- Blood (6 papers)Therapeutic Innovation & Regulatory Science (2 papers)BMC Cancer (1 paper)HemaSphere (1 paper)The Lancet (1 paper)
- Partner nations
- United StatesCzechiaUnited Kingdom
In The Last Decade
Sunhee Kwon Ro
21 papers receiving 1.1k citations
Sunhee Kwon Ro's Hit Papers
Peers
Comparison fields: 5 of 49
- Genetics 382
- Hematology 261
- Cancer Research 128
- Oncology 116
- Pathology and Forensic Medicine 75
Countries citing papers authored by Sunhee Kwon Ro
This map shows the geographic impact of Sunhee Kwon Ro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sunhee Kwon Ro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sunhee Kwon Ro more than expected).
Fields of papers citing papers by Sunhee Kwon Ro
This network shows the impact of papers produced by Sunhee Kwon Ro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sunhee Kwon Ro. The network helps show where Sunhee Kwon Ro may publish in the future.
Co-authors
The 25 scholars most cited alongside Sunhee Kwon Ro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study Hit paper breakdown → | 2020 | 368 |
| 2 | 2012 | 146 | |
| 3 | Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study Hit paper breakdown → | 2023 | 146 |
| 4 | 2019 | 108 | |
| 5 | 2012 | 75 | |
| 6 | 2018 | 65 | |
| 7 | 2013 | 58 | |
| 8 | 2017 | 57 | |
| 9 | 2006 | 50 | |
| 10 | 2012 | 44 | |
| 11 | 2023 | 11 | |
| 12 | 2025 | 11 | |
| 13 | 2011 | 10 | |
| 14 | 2005 | 6 | |
| 15 | 2015 | 6 | |
| 16 | 2023 | 6 | |
| 17 | 2020 | 4 | |
| 18 | 2017 | 2 | |
| 19 | 2005 | 1 | |
| 20 | 2022 | 1 |
About Sunhee Kwon Ro
Sunhee Kwon Ro is a scholar working on Hematology, Genetics, Statistics and Probability, Cancer Research and Oncology, having authored 22 papers that have together received 1.2k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Cancer Treatment and Pharmacology (3 papers), Statistical Methods in Clinical Trials (3 papers), Breast Cancer Treatment Studies (3 papers), Gene expression and cancer classification (2 papers) and Acute Myeloid Leukemia Research (2 papers). The work is most often cited by research in Genetics (382 citations), Hematology (261 citations), Cancer Research (128 citations), Oncology (116 citations) and Pathology and Forensic Medicine (75 citations). Sunhee Kwon Ro has collaborated with scholars based in United States, Czechia and United Kingdom. Frequent co-authors include Heinz Ludwig, Roman Hájek, Kefei Zhou, Ola Landgren, Bruno Paiva, Hui Yang, María‐Victoria Mateos, Hervé Avet‐Loiseau, Barbara Jane Klencke and Richard P. Bryce. Their work appears in journals such as Blood, Therapeutic Innovation & Regulatory Science, BMC Cancer, HemaSphere and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.